STOCK TITAN

Astrana Health’s John Vong surrenders 556 shares

Astrana Health, Inc. (ASTH) reports that its SVP - Accounting (PAO), John Vong, surrendered 556 common shares to offset tax withholding obligations associated with restricted stock units that vested on October 10, 2026.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Astrana Health, Inc. (ASTH) reports that its SVP - Accounting (PAO), John Vong, surrendered 556 common shares to offset tax withholding obligations associated with restricted stock units that vested on October 10, 2026. The reported price was $37.55 per share. John Vong held 21,774 shares directly after the transaction. No Rule 10b5-1 plan is reported.

Insider Vong John
Role SVP - Accounting (PAO)
Type Security Shares Price Value
Tax Withholding Common Stock F1, F2, F3 556 $37.55 $21K
Holdings After Transaction: Common Stock — 21,774 shares (Direct)
Footnotes (3)
  1. F1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 10, 2026.
  2. F2. Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,552 restricted stock units, which will vest on April 10, 2027; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027.
  3. F3. Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan.
Shares surrendered for tax withholding 556 shares October 10, 2026
Reported price per share $37.55 per share October 10, 2026 transaction
Direct shares held after transaction 21,774 shares After the October 10, 2026 transaction
restricted stock units financial
"certain restricted stock units that vested on October 10, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Purchase Plan financial
"acquired under the Issuer's Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
semi-annual installments financial
"vest in seven equal semi-annual installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ASTH shares did John Vong surrender for tax withholding?

John Vong surrendered 556 common shares at a reported price of $37.55 per share on October 10, 2026. The shares offset tax withholding obligations associated with restricted stock units that vested that day; his reported direct holdings afterward were 21,774 shares. No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Vong John

(Last)(First)(Middle)
C/O ASTRANA HEALTH, INC.
1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)
ALHAMBRA CALIFORNIA 91801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP - Accounting (PAO)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/10/2026F556(1)D$37.5521,774(2)(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on October 10, 2026.
2. Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 1,552 restricted stock units, which will vest on April 10, 2027; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027.
3. Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan.
/s/ Kimberly Pham, as Attorney-in-Fact10/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading